Stay updated on Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing the previous v3.6.3 label and indicating an updated version of the content.
    Difference
    0.0%
    Check dated 2026-07-23T05:43:27.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision: v3.6.3 is now displayed, replacing v3.6.0. This indicates a minor update to the page's revision history/documentation rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-07-01T12:27:41.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page now includes new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and an updated Intervention/Treatment label, and it notes that recruitment is closed ('No longer looking for participants') with a revision update to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-16T05:33:43.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.4 to v3.5.5, indicating a small platform maintenance update. This change does not alter any study information or visible content.
    Difference
    0.0%
    Check dated 2026-06-09T03:11:49.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4, representing a maintenance update to the page’s version. No visible changes to study information or functionality are evident.
    Difference
    0.0%
    Check dated 2026-05-18T13:51:36.000Z thumbnail image
  9. Check
    101 days ago
    Change Detected
    Summary
    Updates the displayed ClinicalTrials.gov page revision version in the footer (from v3.5.2 to v3.5.3).
    Difference
    0.0%
    Check dated 2026-04-26T15:34:22.000Z thumbnail image

Stay in the know with updates to Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial page.